查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519340

2024-2032 年按刺激類型、設備類型、應用、最終用戶和地區分類的神經刺激設備市場報告

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球神經刺激設備市場規模達87億美元。人口老化的加劇、醫療保健支出的增加、非侵入性或微創神經刺激技術的發展以及政府和私人健康保險公司改進的報銷政策是推動市場的一些主要因素。

神經刺激設備是先進的醫療技術，旨在調節和影響人體內的神經活動。這些設備透過向神經系統的特定區域傳遞電或磁脈衝來發揮作用，旨在緩解各種神經系統疾病和慢性疾病。它們提供了一種有前途的非侵入性或微創治療方法，提高了患者的生活品質，並有可能為治療各種神經系統疾病開闢新途徑。神經刺激裝置的兩種主要類型是深部腦部刺激和脊髓刺激。 DBS 涉及將電極植入目標大腦區域，以調節異常神經訊號並治療帕金森氏症、特發性震顫和肌張力失調等疾病。

日益成長的老齡化人口正在推動全球市場的發展。隨著老年人口的成長，對治療這些疾病的神經刺激設備的需求可能會增加。此外，非侵入性或微創神經刺激技術的發展擴大了潛在的患者群體，因為與傳統外科手術相比，這些選擇通常可以降低風險並縮短恢復時間。此外，一些地區政府和私人醫療保險公司改善了報銷政策，使患者更容易獲得神經刺激治療，從而鼓勵了市場成長。此外，正在進行的研究和臨床試驗為神經刺激裝置的安全性和有效性提供了更多證據。這些研究的正面結果增強了醫療專業人員和患者對該技術的信心。此外，不斷成長的醫療保健支出正在支持市場解決方案的成長，因為神經刺激設備為管理慢性病提供了一種經濟有效的方法，這推動了它們的採用。

神經刺激設備市場趨勢/促進因素：

神經系統疾病的盛行率不斷增加

帕金森氏症、癲癇、慢性疼痛和憂鬱症等神經系統疾病影響著全世界數百萬人，導致沉重的醫療負擔。神經刺激裝置為傳統治療難治或出現嚴重副作用的患者提供了一個有前景的解決方案。深部腦部刺激（DBS）在治療帕金森氏症等運動障礙方面已顯示出顯著的功效，從而增加了對這些設備的需求。此外，慢性疼痛的發生率不斷上升，特別是由於人口老化和久坐的生活方式，刺激了對脊髓刺激（SCS）設備的需求，以在不嚴重依賴藥物的情況下緩解疼痛。隨著政府和醫療機構優先考慮改善患者治療效果並尋求創新解決方案，對神經刺激設備的需求預計將穩定成長。

神經刺激技術的不斷進步

持續的研究和開發努力創造了更複雜、更有針對性的神經刺激設備。創新包括更小、更精確的電極、延長的電池壽命以及整合閉迴路系統，該系統可以根據患者的即時需求自動調整刺激參數。這些進步可提高治療效果、減少副作用並提高患者舒適度。此外，植入神經刺激裝置的微創手術的發展已將其適用性擴大到更廣泛的患者群體，使治療更容易獲得，對患者和醫療保健提供者都更有吸引力。隨著技術的不斷發展，神經刺激設備可能會變得更有效率和更具適應性，從而進一步推動其採用和市場滲透。

對神經調節療法的認知和接受度不斷提高

隨著越來越多的臨床證據支持神經刺激裝置在治療各種神經系統疾病的有效性，醫生也擴大向患者推薦這些療法。此外，患者倡導團體和宣傳活動在教育個人神經刺激的潛在益處方面發揮了至關重要的作用，從而提高了患者對這些治療的接受度。透過神經刺激設備顯著改善生活品質的患者的成功故事進一步促進了人們對這些療法的正面看法。隨著對神經調節的信任不斷成長，對這些設備的需求預計會增加，從而推動市場擴張。此外，醫療保健組織、研究人員和設備製造商之間的合作，以傳播意識並確保適當的使用，將有助於神經刺激設備市場的持續成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球神經刺激設備市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按刺激類型

  • 內部刺激
    • 市場走向
    • 市場預測
  • 外部刺激
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按設備類型

  • SCS（脊髓刺激）設備
    • 市場走向
    • 市場預測
  • DBS（深部腦部刺激）設備
    • 市場走向
    • 市場預測
  • SNS（薦神經刺激）設備
    • 市場走向
    • 市場預測
  • VNS（迷走神經刺激）設備
    • 市場走向
    • 市場預測
  • GES（胃電刺激）設備
    • 市場走向
    • 市場預測
  • 經皮神經電刺激裝置
    • 市場走向
    • 市場預測
  • 經顱磁刺激裝置
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 疼痛管理
    • 市場走向
    • 市場預測
  • 癲癇
    • 市場走向
    • 市場預測
  • 特發性震顫
    • 市場走向
    • 市場預測
  • 尿失禁和大便失禁
    • 市場走向
    • 市場預測
  • 沮喪
    • 市場走向
    • 市場預測
  • 肌張力失調
    • 市場走向
    • 市場預測
  • 帕金森氏症
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 復健中心
    • 市場走向
    • 市場預測
  • 醫院
    • 市場走向
    • 市場預測
  • 醫療診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

  • 概述
  • 入境物流
  • 營運
  • 出境物流
  • 行銷與銷售
  • 售後服務

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格指標

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Biocontrol Medical
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • Medtronic Inc.
    • Neuronetics Inc.
    • Neuropace Inc.
    • Neurosigma Inc.
    • Nevro Corporation
    • ST. Jude Medical Inc.
    • Synapse Biomedical Inc.
Product Code: SR112024A1892

The global neurostimulation devices market size reached US$ 8.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.6 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.

Neurostimulation devices are advanced medical technologies designed to modulate and influence neural activity within the human body. These devices work by delivering electrical or magnetic impulses to specific regions of the nervous system, aiming to alleviate various neurological conditions and chronic disorders. They offer a promising non-invasive or minimally invasive therapeutic approach, enhancing the quality of life for patients and potentially opening up new avenues for treating various neurological disorders. The two primary types of neurostimulation devices are deep brain stimulation and spinal cord stimulation. DBS involves implanting electrodes into targeted brain areas to regulate abnormal neural signals and treat conditions such as Parkinson's disease, essential tremor, and dystonia.

The growing aging population is driving the global market. As the elderly population grows, the demand for neurostimulation devices to manage these conditions is likely to rise. Moreover, the development of non-invasive or minimally invasive neurostimulation technologies has expanded the potential patient pool, as these options often offer reduced risks and quicker recovery times compared to traditional surgical procedures. Besides, improved reimbursement policies by government and private health insurers in some regions have made neurostimulation treatments more accessible to patients, encouraging market growth. Also, ongoing research and clinical trials have provided additional evidence for the safety and efficacy of neurostimulation devices. Positive results from these studies have increased confidence in the technology among medical professionals and patients. Furthermore, the rising healthcare expenditure is supporting the growth of market solutions as neurostimulation devices offer a cost-effective approach to managing chronic conditions, which has driven their adoption.

Neurostimulation Devices Market Trends/Drivers:

Increasing Prevalence of Neurological Disorders

Neurological conditions such as Parkinson's disease, epilepsy, chronic pain, and depression affect millions of people worldwide, leading to significant healthcare burdens. Neurostimulation devices offer a promising solution for patients who are refractory to conventional treatments or experience severe side effects. Deep brain stimulation (DBS) has demonstrated remarkable efficacy in managing movement disorders, such as Parkinson's disease, thereby augmenting the demand for these devices. Additionally, the escalating incidence of chronic pain, particularly due to aging populations and sedentary lifestyles, fuels the need for spinal cord stimulation (SCS) devices to provide pain relief without relying heavily on medications. As governments and healthcare organizations prioritize improved patient outcomes and seek innovative solutions, the demand for neurostimulation devices is expected to grow steadily.

Continual Advancements in Neurostimulation Technologies

Continuous research and development efforts have led to the creation of more sophisticated and targeted neurostimulation devices. Innovations include smaller and more precise electrodes, improved battery life, and the integration of closed-loop systems that can automatically adjust stimulation parameters based on real-time patient needs. These advancements translate to enhanced treatment outcomes, reduced side effects, and increased patient comfort. Moreover, the development of minimally invasive procedures for implanting neurostimulation devices has expanded their applicability to a broader patient population, making the treatments more accessible and appealing to both patients and healthcare providers. As technology continues to evolve, neurostimulation devices will likely become even more efficient and adaptable, further impelling their adoption and market penetration.

Growing Awareness and Acceptance of Neuromodulation Therapies

As more clinical evidence supports the effectiveness of neurostimulation devices in treating various neurological disorders, medical practitioners increasingly recommend these therapies to their patients. Additionally, patient advocacy groups and awareness campaigns have played a crucial role in educating individuals about the potential benefits of neurostimulation, leading to greater patient acceptance of these treatments. The success stories of patients who have experienced significant improvements in their quality of life through neurostimulation devices have further contributed to the positive perception of these therapies. As trust in neuromodulation grows, the demand for these devices is expected to increase, fuelling the market expansion. Furthermore, collaborations between healthcare organizations, researchers, and device manufacturers to spread awareness and ensure appropriate usage will contribute to the sustained growth of the neurostimulation devices market.

Neurostimulation Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global neurostimulation devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on stimulation type, device type, application, and end-user.

Breakup by Stimulation Type:

Internal Stimulation

External Stimulation

The report has provided a detailed breakup and analysis of the market based on the stimulation type. This includes internal stimulation and external stimulation.

Internal stimulation devices form a significant segment within the neurostimulation market, characterized by their implantable nature. These devices are surgically placed within the body to deliver targeted electrical or magnetic stimulation directly to specific neural structures. The demand for internal stimulation devices is driven by their efficacy in managing complex neurological disorders that do not respond adequately to medications or other treatments. The ability to precisely target neural circuits while providing reversible and adjustable stimulation parameters enhances treatment outcomes, leading to improved patient quality of life.

On the other hand, external stimulation devices represent another substantial segment in the neurostimulation market, characterized by their non-invasive or minimally invasive nature. These devices are applied externally to the body's surface, delivering stimulation without the need for surgical implantation.

Breakup by Device Type:

SCS (Spinal Cord Stimulation) Devices

DBS (Deep Brain Stimulation) Devices

SNS (Sacral Nerve Stimulation) Devices

VNS (Vagus Nerve Stimulation) Devices

GES (Gastric Electrical Stimulation) Devices

Transcutaneous Electrical Nerve Stimulation Devices

Transcranial Magnetic Stimulation Devices

Others

SCS (spinal cord stimulation) dominates the market

The report has provided a detailed breakup and analysis of the market based on the device type. This includes spinal cord stimulation (SCS) devices, deep brain stimulation (DBS) devices, sacral nerve stimulation (SNS) devices, vagus nerve stimulation (VNS) devices, gastric electrical stimulation (GES) devices, transcutaneous electrical nerve stimulation devices, transcranial magnetic stimulation devices, and other. According to the report, SCS (spinal cord stimulation) devices represented the largest segment.

SCS involves the implantation of electrodes along the spinal cord, where electrical impulses are delivered to modulate pain signals and provide relief for chronic pain conditions. The minimally invasive nature of the procedure offers numerous benefits, including shorter recovery times and reduced risks compared to invasive surgeries. Additionally, the customizable nature of SCS allows for individualized programming to target specific pain areas, tailoring treatment to meet each patient's unique needs. Moreover, continual advancements in SCS technology have led to more sophisticated devices with improved battery life, smaller implants, and enhanced programming capabilities, providing greater patient comfort and long-term sustainability. The focus on patient-centered care and shared decision-making has led to an increased emphasis on personalized pain management plans. Spinal cord stimulation, with its individualized programming capabilities, aligns well with this patient-centric approach, fueling its adoption in pain management strategies.

Breakup by Application:

Pain Management

Epilepsy

Essential Tremors

Urinary and Fecal Incontinence

Depression

Dystonia

Parkinson's Disease

Others

Pain management dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes pain management, epilepsy, essential tremors, urinary and fecal incontinence, depression, dystonia, Parkinson's disease, and others. According to the report, pain management represents the largest segment.

Neurostimulation devices designed for pain management offer a promising alternative, particularly spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies work by delivering controlled electrical impulses to target nerves, modulating pain signals, and thereby reducing the perception of pain. Pain management through neurostimulation has demonstrated remarkable efficacy in various chronic pain conditions, including neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Additionally, the advancements in neurostimulation technology have led to more personalized and precise pain management solutions, allowing for tailored treatment strategies based on individual patient needs.

Breakup by End-User:

Rehabilitation Centers

Hospitals

Medical Clinics

Others

Hospitals dominates the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes rehabilitation centers, hospitals, medical clinics, and others. According to the report, hospitals represented the largest segment.

Hospitals play a central role in the diagnosis, treatment, and management of various neurological and chronic disorders, which often require neurostimulation therapies as part of the treatment plan. Hospitals have access to multidisciplinary teams of medical professionals, including neurologists, neurosurgeons, pain specialists, and anesthesiologists, who collaborate to provide comprehensive care to patients requiring neurostimulation therapies. Additionally, they are equipped with state-of-the-art operating rooms and facilities that meet stringent regulatory standards, ensuring safe and effective implantation procedures. Furthermore, neurostimulation devices often require careful programming and adjustments to optimize treatment outcomes, and hospitals have the resources to support these ongoing patient management needs.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurostimulation devices market share.

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Latin America (Brazil, Mexico, and Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established healthcare infrastructure and is at the forefront of medical research and technological advancements. The presence of leading healthcare facilities, specialized neurology centers, and renowned research institutions fosters innovation and the adoption of cutting-edge neurostimulation technologies. Moreover, the region has a high prevalence of neurological disorders and chronic pain conditions, leading to a substantial demand for neurostimulation devices for effective management and treatment. The region's aging population, coupled with a growing awareness of neurostimulation therapies among patients and healthcare providers, further fuels market growth. Additionally, favorable reimbursement policies and regulatory frameworks in North America support the widespread adoption of neurostimulation devices.

Competitive Landscape:

Neurostimulation device manufacturers are heavily investing in research and development to enhance their existing products and develop new, innovative technologies. This involves conducting clinical trials, exploring new applications for neurostimulation, and improving the safety and efficacy of their devices. Moreover, companies are introducing new neurostimulation devices or release upgraded versions of existing ones. These launches aim to provide patients and healthcare professionals with state-of-the-art solutions that offer better outcomes and user experiences. Furthermore, companies actively seek to expand their market presence, both geographically and in terms of applications. They may pursue regulatory approvals in different regions, explore new therapeutic areas for neurostimulation, or target specific patient populations with unmet needs. Also, collaboration with other companies, research institutions, and healthcare organizations is common in the neurostimulation devices market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Biocontrol Medical

Boston Scientific Corporation

Cyberonics Inc.

Medtronic Inc.

Neuronetics Inc.

Neuropace Inc.

Neurosigma Inc.

Nevro Corporation

ST. Jude Medical Inc.

Synapse Biomedical Inc.

Recent Developments:

In April 2023, Synapse Biomedical Inc. received the approval for diaphragm pacing system, NeuRx DPS(R). The NeuRx DPS(R) is a battery-powered device that delivers electrical stimulation via four percutaneous intramuscular electrodes implanted into the diaphragm with minimally invasive laparoscopy. It is intended for use in patients with stable SCI with stimulatable diaphragms, but who lack control of their diaphragms. The device is indicated to allow patients 18 years and older to breathe without the assistance of a mechanical ventilator for at least four continuous hours a day.

In March 2023, Nevro Corporation announced the Launch of Revolutionary HFX iQ(TM) Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain. It combines clinical inputs, such as pain relief and pain score, along with quality of life inputs, such as pain medication and activity level changes, to provide an individualized program setting for each patient.

In September 2022, Neuronetics Inc. launched Innovations to NeuroStar(R) Advanced Therapy's Proprietary TrakStar(R) Platform. The TrakStar upgrades include a simplified interface to quickly sort and prioritize potential patients with ease. It also streamlines the patient journey by bridging our proprietary PHQ-10 platform with our HIPAA-compliant TrakStar patient data management system making it easier to identify new patients and those needing re-treatment.

Key Questions Answered in This Report

  • 1. What was the size of the global neurostimulation devices market in 2023?
  • 2. What is the expected growth rate of the global neurostimulation devices market during 2024-2032?
  • 3. What are the key factors driving the global neurostimulation devices market?
  • 4. What has been the impact of COVID-19 on the global neurostimulation devices market?
  • 5. What is the breakup of the global neurostimulation devices market based on the device type?
  • 6. What is the breakup of the global neurostimulation devices market based on the application?
  • 7. What is the breakup of the global neurostimulation devices market based on the end-user?
  • 8. What are the key regions in the global neurostimulation devices market?
  • 9. Who are the key players/companies in the global neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External Stimulation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Essential Tremors
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Depression
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Dystonia
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Parkinson's Disease
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Post Sales Services

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biocontrol Medical
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boston Scientific Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Cyberonics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Medtronic Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Neuronetics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Neuropace Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Neurosigma Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nevro Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 ST. Jude Medical Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Synapse Biomedical Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2023
  • Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2023
  • Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2023
  • Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
  • Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
  • Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million US$), 2024-2032
  • Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Neurostimulation Devices Market: Competitive Structure
  • Table 8: Global: Neurostimulation Devices Market: Key Players